PT Kalbe Farma Tbk. (PTKFF)

USD 0.08

(0.0%)

Total Liabilities Summary of PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.'s latest annual total liabilities in 2023 was 255.94 Million USD , down -22.26% from previous year.
PT Kalbe Farma Tbk.'s latest quarterly total liabilities in 2024 Q2 was 306.56 Million USD , up 0.36% from previous quarter.
PT Kalbe Farma Tbk. reported annual total liabilities of 329.21 Million USD in 2022, up 6.87% from previous year.
PT Kalbe Farma Tbk. reported annual total liabilities of 308.05 Million USD in 2021, up 0.93% from previous year.
PT Kalbe Farma Tbk. reported quarterly total liabilities of 305.45 Million USD for 2024 Q1, up 19.35% from previous quarter.
PT Kalbe Farma Tbk. reported quarterly total liabilities of 306.56 Million USD for 2024 Q2, up 0.36% from previous quarter.

Annual Total Liabilities Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Total Liabilities of PT Kalbe Farma Tbk. (2023 - 2015)

Year	Total Liabilities	Total Liabilities Growth
2023	255.94 Million USD	-22.26%
2022	329.21 Million USD	6.87%
2021	308.05 Million USD	0.93%
2020	305.21 Million USD	19.05%
2019	256.37 Million USD	29.28%
2018	198.3 Million USD	-1.17%
2017	200.64 Million USD	-2.14%
2016	205.02 Million USD	2.47%
2015	200.08 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q3	319.44 Million USD	1578687.32%
2024 Q1	305.45 Million USD	19.35%
2024 Q2	306.56 Million USD	0.36%
2023 Q3	312.52 Million USD	-17.34%
2023 FY	255.94 Million USD	-22.26%
2023 Q2	378.07 Million USD	7.71%
2023 Q1	351.02 Million USD	6.62%
2023 Q4	255.94 Million USD	-18.1%
2022 Q4	329.21 Million USD	0.53%
2022 FY	329.21 Million USD	6.87%
2022 Q3	327.49 Million USD	7.82%
2022 Q1	339.17 Million USD	10.1%
2022 Q2	303.74 Million USD	-10.45%
2021 Q1	308.15 Million USD	0.0%
2021 FY	308.05 Million USD	0.93%
2021 Q3	299.25 Million USD	6.07%
2021 Q4	308.05 Million USD	2.94%
2021 Q2	282.11 Million USD	-8.45%
2020 FY	305.21 Million USD	19.05%
2019 FY	256.37 Million USD	29.28%
2018 FY	198.3 Million USD	-1.17%
2017 FY	200.64 Million USD	-2.14%
2016 FY	205.02 Million USD	2.47%
2015 FY	200.08 Million USD	0.0%

Peer Total Liabilities Comparison of PT Kalbe Farma Tbk.

Name	Total Liabilities	Total Liabilities Difference
AstraZeneca PLC	61.86 Billion USD	99.586%
Bristol-Myers Squibb Company PFD CONV 2	65.67 Billion USD	99.61%
CSPC Pharmaceutical Group Limited	1.53 Billion USD	83.378%
Clarus Therapeutics Holdings, Inc.	67.62 Million USD	-278.459%
Novartis AG	53.19 Billion USD	99.519%